The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome
Open Access
- 2 May 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 12 (4) , 351-361
- https://doi.org/10.1093/humupd/dml017
Abstract
Polycystic ovary syndrome (PCOS) is a common clinical disorder characterized by ovulatory dysfunction and hyperandrogenaemia. A neuroendocrine hallmark of PCOS is persistently rapid LH (GnRH) pulsatility, which favours pituitary synthesis of LH over that of FSH and contributes to the increased LH concentrations and LH : FSH ratios typical of PCOS. Inadequate FSH levels contribute to impaired follicular development, whereas elevated LH levels augment ovarian androgen production. Whereas luteal phase elevations in progesterone normally slow GnRH pulse frequency, women with PCOS do not experience normal progesterone-mediated slowing, due in part to impaired hypothalamic progesterone sensitivity. This reduction in hypothalamic progesterone sensitivity appears to be mediated by elevated androgens because sensitivity can be restored with the androgen receptor blocker flutamide. The ovulatory and hormonal abnormalities associated with PCOS generally present during puberty, typically associated with hyperandrogenaemia. Along with elevated LH concentration and pulsatility, some girls with hyperandrogenaemia have impaired hypothalamic progesterone sensitivity similar to that seen in adult women with PCOS. We propose that peripubertal hyperandrogenaemia may lead to persistently rapid GnRH pulse frequency via impaired hypothalamic feedback inhibition. The subsequent abnormalities in gonadotropin secretion, androgen production and ovulatory function may support progression towards the adult PCOS phenotype.Keywords
This publication has 101 references indexed in Scilit:
- Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?Human Reproduction Update, 2005
- Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 2005
- Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivityFertility and Sterility, 2004
- Polycystic Ovarian Morphology with Regular Ovulatory Cycles: Insights into the Pathophysiology of Polycystic Ovarian SyndromeJournal of Clinical Endocrinology & Metabolism, 2004
- The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected PopulationJournal of Clinical Endocrinology & Metabolism, 2004
- Metformin directly inhibits androgen production in human thecal cellsFertility and Sterility, 2001
- Endocrine Determinants of Fertility: Serum Androgen Concentrations during Follow-up of Adolescents into the Third Decade of Life*Journal of Clinical Endocrinology & Metabolism, 1990
- OPIOIDERGIC REGULATION OF LH PULSATILITY IN WOMEN WITH POLYCYSTIC OVARY SYNDROMEClinical Endocrinology, 1989
- Insulin Stimulates Androgen Accumulation in Incubations of Ovarian Stroma Obtained from Women with Hyperandrogenism*Journal of Clinical Endocrinology & Metabolism, 1986
- Insulin Enhancement of Luteinizing Hormone and Follicle-Stimulating Hormone Release by Cultured Pituitary Cells*Endocrinology, 1981